Salud Mental

Factors associated with retention in faith-based drug treatment centers in the Mexican-American border

##plugins.themes.bootstrap3.article.main##

Ietza Bojorquez
Daniel Rodríguez
Olga Odgers
Ramiro Jaimes

Abstract

Introduction. Faith-based centers are major providers of residential treatment for substance use problems in Mexico, but relatively few studies have been conducted in this context.

Objective. To explore factors associated with treatment retention in two faith-based (with different religious orientation) residential treatment facilities for male drug users in Tijuana, Mexico.

Method. We conducted an exploratory follow-up study of 328 clients admitted during 2014-2015 to either an Evangelical Pentecostal center or a faith-based center without a specific religious affiliation. The main outcome was retention, defined as remaining in treatment for at least three months.

Results. Among participants, the retention rate was 38.7%. Multivariate logistic regression models showed that age (OR 1.04; 95% CI [1.01, 1.06]; p = .002) and having used heroin or opioids in the past 30 days (OR .50; 95% CI [.25, 1.00]; p = .049) were associated with retention. Having a personal religious affiliation was associated with retention in the Evangelical Pentecostal center, but not in the center without a specific religious affiliation. Discussion and conclusion. The retention rate was low, but within the previously reported range. The interaction of personal religious affiliation and the religious orientation of the center suggests that a match between a person’s religious convictions and those of the center could be important for retention. More research is needed to clarify the utility of faith-based centers for religious and non-religious drug users.

Keywords:
Drug users, residential treatment, faith-based treatment, Mexico

Downloads

Download data is not yet available.

References

Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006). Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence, 81(3), 313-322.doi:10.1016/j.drugalcdep.2005.08.003

American Psychiatric Association/Work Group on Substance Use Disorders. (2010). Practice Guideline for the Treatment of Patients With Substance Use Disorders: American Psychiatric Association.

Arndt, S., Acion, L., & White, K. (2013). How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities. Drug and Alcohol Dependence, 132(3), 547-554. doi:10.1016/j.drugalcdep.2013.03.015

Carver, C. S. (1997). You want to measure coping but your protocol's too long: consider the brief COPE. International Journal of Behavioral Medicine, 4(1), 92-100. doi:10.1207/s15327558ijbm0401_6

Evans, E., Li, L., & Hser, Y. I. (2009). Client and program factors associated with dropout from court mandated drug treatment. Evaluation and Program Planning, 32(3), 204-212. doi:10.1016/j.evalprogplan.2008.12.003

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.

Galaviz, G., & Odgers, O. (2014). Estado laico y alternativas terapéuticas religiosas. El caso de México en el tratamiento de adicciones. Debates do NER, 26, 253-276.

Garcia, A. (2015). Serenity: Violence, Inequality, and Recovery on the Edge of Mexico City. Medical Anthropology Quarterly, 29(4), 455-472. doi:10.1111/maq.12208

Garnick, D. W., Lee, M. T., Horgan, C. M., Acevedo, A., & Washington Circle Public Sector, W. (2009). Adapting Washington Circle performance measures for public sector substance abuse treatment systems. Journal of Substance Abuse Treatment, 36(3), 265-277. doi:10.1016/j.jsat.2008.06.008

Hall, E. A. (2001). Feelings about drug use: Drug-related locus of control. Los Angeles, CA: UCLA Integrated Substance Abuse Programs.

Instituto Nacional de Psiquatría Ramón de la Fuente Muñiz; Instituto Nacional de Salud Pública; Comisión Nacional Contra las Adicciones; Secretaría de Salud. (2017). Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017: Reporte de Drogas. Ciudad de México, México: INPRFM.

Koenig, H. C., & Büssing, A. (2010). The Duke University Religion Index (DUREL): A Five-Item Measure for Use in Epidemological Studies. Religions, 1(1), 78-85.

Lang, M. A., & Belenko, S. (2000). Predicting retention in a residential drug treatment alternative to prison program. Journal of Substance Abuse Treatment, 19(2), 145-160.

Lewandowski, C. A., & Hill, T. J. (2009). The impact of emotional and material social support on women's drug treatment completion. Health & Social Work, 34(3), 213-221.

Lozano-Verduzco, I., Marin-Navarrete, R., Romero-Mendoza, M., & Tena-Suck, A. (2015). Experiences of Power and Violence in Mexican Men Attending Mutual-Aid Residential Centers for Addiction Treatment. American Journal of Men's Health. doi:10.1177/1557988314565812

Marín-Navarrete, R., Eliosa-Hernández, A., Lozano-Verduzco, I., Fernández-De la Fuente, C., Turnbull, B., & Tena-Suck, A. (2013). Estudio sobre la experiencia de hombres atendidos en centros residenciales de ayuda mutua para la atención de las adicciones. Salud Mental, 36, 393-402.

McKellar, J., Kelly, J., Harris, A., & Moos, R. (2006). Pretreatment and during treatment risk factors for dropout among patients with substance use disorders. Addictive Behaviors, 31(3), 450-460. doi:10.1016/j.addbeh.2005.05.024

Meier, P. S., & Best, D. (2006). Programme factors that influence completion of residential treatment. Drug and Alcohol Review, 25(4), 349-355. doi:10.1080/09595230600741230

Meier, P. S., Donmall, M. C., McElduff, P., Barrowclough, C., & Heller, R. F. (2006). The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence, 83(1), 57-64. doi:10.1016/j.drugalcdep.2005.10.010

Mokri, H., Avila-Funes, J. A., Meillon, C., Gutierrez Robledo, L. M., & Amieva, H. (2013). Normative data for the Mini-Mental State Examination, the Free and Cued Selective Reminding Test and the Isaacs Set Test for an older adult Mexican population: the Coyoacan cohort study. The Clinical Neuropsychologist, 27(6), 1004-1018. doi:10.1080/13854046.2013.809793

Mulder, R. T., Frampton, C. M., Peka, H., Hampton, G., & Marsters, T. (2009). Predictors of 3-month retention in a drug treatment therapeutic community. Drug and Alcohol Review, 28(4), 366-371. doi:10.1111/j.1465-3362.2009.00050.x

Odgers, O., Galaviz, G., & Hernandez, A. (2009). Tendencias del cambio religioso en la región norte de México. In A. Hernandez & C. Rivera (Eds.), Regiones y religionesen México, estudios de la transformación sociorreligiosa. Tijuana: El Colegio de la Frontera Norte,.

Parhami, I., Davtian, M., Collard, M., Lopez, J., & Fong, T. W. (2014). A preliminary 6-month prospective study examining self-reported religious preference, religiosity/spirituality, and retention at a Jewish residential treatment center for substance-related disorders. The Journal of Behavioral Health Services & Research, 41(3), 390-401. doi:10.1007/s11414-012-9279-x

Secretaría de Salud (SSA). (2015). Sistema de Vigilancia Epidemiológica para las Adicciones. Informe 2014. Mexico: SSA.

StataCorp. (2013). Stata Statistical Software: Release 13. College Station, TX: StataCorp LP.

Stoll, D. (1990). Is Latin America Turning Protestant? The Politics of Evangelical Growth. Berkeley: University of California Press.

Sung, H. E., & Chu, D. C. (2013). The varieties of religious experience and the retention of clients in Taiwanese faith-based residential drug user treatment. Substance Use & Misuse, 48(12), 1219-1232. doi:10.3109/10826084.2013.805597

Tate, S. R., Wu, J., McQuaid, J. R., Cummins, K., Shriver, C., Krenek, M., & Brown, S. A. (2008). Comorbidity of substance dependence and depression: role of life stress and self-efficacy in sustaining abstinence. Psychology of Addictive Behaviors, 22(1), 47-57. doi:10.1037/0893-164X.22.1.47

Zhang, Z., Friedmann, P. D., & Gerstein, D. R. (2003). Does retention matter? Treatment duration and improvement in drug use. Addiction, 98(5), 673-684.